XML 145 R58.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Acquisitions (Narrative) (Details)
$ in Millions
6 Months Ended 12 Months Ended
Mar. 01, 2019
USD ($)
Feb. 25, 2019
USD ($)
Apr. 13, 2018
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2019
USD ($)
Business
Businesses
Dec. 31, 2018
USD ($)
Business
Dec. 31, 2017
USD ($)
Business
Business Acquisition [Line Items]              
Revenues of pending product lines disposal         $ 170.0    
Net cash consideration         $ 331.3 $ 2,173.3 $ 385.8
Number of segments | Business         3    
Goodwill         $ 217.1 1,275.4 $ 264.8
GE Biopharma Acquisition              
Business Acquisition [Line Items]              
Consideration transferred   $ 21,000.0          
Pension liabilities assumed   $ 400.0          
Proceeds from underwritten public offerings of stock $ 3,000.0            
Proceeds from issuance of debt       $ 10,800.0      
Proceeds from commercial paper borrowings and cash on hand         7,200.0    
Transaction costs       $ 93.0 $ 93.0    
IDT              
Business Acquisition [Line Items]              
Net cash consideration     $ 2,100.0     2,078.2  
Revenue reported by acquired entity for last annual period     260.0        
Goodwill     $ 1,200.0     1,212.6  
Transaction costs           $ 15.0  
Other businesses acquired              
Business Acquisition [Line Items]              
Number of businesses acquired         5 1 9
Net cash consideration         $ 331.0 $ 95.1 $ 386.0
Revenue reported by acquired entity for last annual period         72.0 53.0 160.0
Goodwill         $ 217.0 62.8 $ 265.0
Fair value adjustment to inventory | IDT              
Business Acquisition [Line Items]              
Fair value adjustments to inventory           $ 1.0